BYSI logo

BeyondSpring Inc.

BYSI
Healthcare|Biotechnology|US
$0.63
-0.01 (-1.01%)
DCF Value
$0.18
Cash / Share
$0.16
Next Earnings Report
Nov 12, 2026
EPS est. -$0.54 · Revenue est. $8.8M
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest Sep 29, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Awaiting Results (2)

Trials past primary completion date but still active — data readout may be imminent.

Nov 2026
P2
Study of Plinabulin and Pegfilgrastim in People With Multiple Myeloma Undergoing an Autologous Hematopoietic Stem Cell Transplant (AHCT)
NCT05130827
May 2025
P2
Pembrolizumab in Combination With Plinabulin and Docetaxel For Metastatic NSCLC After ICIs (KeyPemls-004)
NCT05599789

Recent Press Releases

BeyondSpring Announces FDA Fast Track Designation for Plinabulin in Post-ICI Non-Squamous NSCLC and Strategic Transaction to Advance Global Phase 3 DUBLIN-4 Trial Toward Planned Interim Analysis
Sep 29, 2026 · GlobeNewsWire
BeyondSpring Reports Second-Quarter 2026 Financial Results and Provides Corporate Update
Aug 14, 2026 · GlobeNewsWire

SEC Filings (46)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 29, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Oct 13, 20268-KMaterial eventDocumentIndex
Oct 6, 20268-KMaterial eventDocumentIndex
Oct 2, 20268-KMaterial eventDocumentIndex
Sep 29, 20268-KMaterial eventDocumentIndex
Sep 29, 2026424B5Offering prospectusDocumentIndex
Sep 18, 20268-KMaterial eventDocumentIndex
Sep 3, 2026DEFA14AProxy / shareholder voteDocumentIndex
Sep 3, 2026DEF 14AProxy / shareholder voteDocumentIndex
Sep 3, 2026ARSAnnual report to holdersDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 202610-QQuarterly reportDocumentIndex
Aug 14, 20268-KMaterial eventDocumentIndex
Jun 29, 20268-K/AMaterial eventDocumentIndex
Jun 4, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 13, 202610-QQuarterly reportDocumentIndex
May 13, 20268-KMaterial eventDocumentIndex
Mar 25, 202610-KAnnual reportDocumentIndex
Mar 25, 20268-KMaterial eventDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Dec 15, 20258-KMaterial eventDocumentIndex
Nov 21, 20258-KMaterial eventDocumentIndex
Nov 17, 2025424B5Offering prospectusDocumentIndex
Nov 12, 202510-QQuarterly reportDocumentIndex
Nov 12, 20258-KMaterial eventDocumentIndex
Sep 23, 20258-KMaterial eventDocumentIndex
Sep 16, 20258-KMaterial eventDocumentIndex
Aug 18, 2025EFFECTDocumentIndex
Aug 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Aug 13, 2025POS AMDocumentIndex
Aug 13, 202510-QQuarterly reportDocumentIndex
Aug 13, 20258-KMaterial eventDocumentIndex
Aug 6, 2025DEF 14AProxy / shareholder voteDocumentIndex
Aug 6, 2025DEFA14AProxy / shareholder voteDocumentIndex
Jul 3, 20258-KMaterial eventDocumentIndex
May 12, 202510-QQuarterly reportDocumentIndex
May 12, 20258-KMaterial eventDocumentIndex
Mar 27, 202510-KAnnual reportDocumentIndex